Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
US Department of Justice
Boehringer Ingelheim
Julphar
Deloitte
Harvard Business School
Accenture
Fuji
Cantor Fitzgerald
Cerilliant

Generated: January 18, 2018

DrugPatentWatch Database Preview

Butabarbital sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for butabarbital sodium and what is the scope of butabarbital sodium patent protection?

Butabarbital sodium
is the generic ingredient in ten branded drugs marketed by Medpointe Pharm Hlc, Alpharma Us Pharms, Wockhardt, Lannett, Meda Pharms, Halsey, Bundy, Sandoz, Solvay, Teva, Watson Labs, Whiteworth Town Plsn, Mylan Speciality Lp, Hikma Pharms, Ivax Sub Teva Pharms, and Marshall Pharma, and is included in thirty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for butabarbital sodium. One supplier is listed for this compound.

US Patents and Regulatory Information for butabarbital sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms SODIUM BUTABARBITAL butabarbital sodium TABLET;ORAL 084040-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Speciality Lp BUTISOL SODIUM butabarbital sodium TABLET;ORAL 000793-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Whiteworth Town Plsn BUTABARBITAL SODIUM butabarbital sodium TABLET;ORAL 083337-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Speciality Lp BUTISOL SODIUM butabarbital sodium TABLET;ORAL 000793-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz BUTABARBITAL SODIUM butabarbital sodium TABLET;ORAL 084272-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva BUTABARBITAL SODIUM butabarbital sodium TABLET;ORAL 088632-001 May 18, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz BUTABARBITAL SODIUM butabarbital sodium TABLET;ORAL 085934-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Medpointe Pharm Hlc BUTICAPS butabarbital sodium CAPSULE;ORAL 085381-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Solvay BUTABARBITAL SODIUM butabarbital sodium TABLET;ORAL 083896-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva BUTABARBITAL SODIUM butabarbital sodium TABLET;ORAL 088631-001 May 1, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Deloitte
Fish and Richardson
Chubb
Argus Health
QuintilesIMS
Daiichi Sankyo
Express Scripts
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot